Pro-inflammatory cytokines in acute coronary syndromes: from bench to bedside

D Tousoulis, C Antoniades, N Koumallos… - Cytokine & growth factor …, 2006 - Elsevier
Cytokines are produced in a variety of tissues and regulate the expression of a number of
inflammatory molecules, leading to destabilization and finally rupture of vulnerable …

Cytokines as therapeutic targets to reduce cardiovascular risk in chronic inflammation

AM Miller, IB McInnes - Current pharmaceutical design, 2011 - ingentaconnect.com
Patients with chronic inflammatory diseases, such as rheumatoid arthritis (RA), systemic
lupus erythematosus, psoriasis and Crohn's disease have an increased atherosclerotic risk …

Cytokines and their role in cardiovascular diseases

H Haybar, B Bandar, E Torfi, A Mohebbi, N Saki - Cytokine, 2023 - Elsevier
The evaluation of diagnostic and prognostic biomarkers has always been a hot topic in
various diseases. Considering that cardiovascular diseases (CVDs) have the highest …

[HTML][HTML] Inflammatory cytokines and atherosclerotic plaque progression. Therapeutic implications

AV Sterpetti - Current Atherosclerosis Reports, 2020 - Springer
Abstract Purpose of the Review Inflammatory cytokines play a major role in atherosclerotic
plaque progression. This review summarizes the rationale for personalized anti …

Targeting early atherosclerosis: a focus on oxidative stress and inflammation

P Marchio, S Guerra-Ojeda, JM Vila… - Oxidative medicine …, 2019 - Wiley Online Library
Atherosclerosis is a chronic vascular inflammatory disease associated to oxidative stress
and endothelial dysfunction. Oxidation of low‐density lipoprotein (LDL) cholesterol is one of …

Inflammation modulation and cardiovascular disease prevention

Z Awan, J Genest - European Journal of Preventive Cardiology, 2015 - academic.oup.com
Heart disease and stroke represent the major burden of health worldwide and account for a
staggering 17 million deaths yearly. This pandemic is, in great part preventable through …

[HTML][HTML] Inflammatory therapeutic targets in coronary atherosclerosis—from molecular biology to clinical application

F Linden, G Domschke, C Erbel… - Frontiers in …, 2014 - frontiersin.org
Atherosclerosis is the leading cause of death worldwide. Over the past two decades, it has
been clearly recognized that atherosclerosis is an inflammatory disease of the arterial wall …

Macrophages in vascular inflammation: origins and functions

JL Decano, PC Mattson, M Aikawa - Current Atherosclerosis Reports, 2016 - Springer
Macrophages influence various processes of cardiovascular inflammation. Whether they are
of embryonic or post-natal hematopoietic origin, their balance in differential activation may …

Atherosclerosis and inflammation. New therapeutic approaches

J Pedro-Botet, E Climent, D Benaiges - Medicina Clínica (English Edition), 2020 - Elsevier
The recognition of atherogenesis as an active process rather than a passive cholesterol
storage disease has underlined key inflammatory mechanisms. Hence, innate and adaptive …

Inflammatory related cardiovascular diseases: from molecular mechanisms to therapeutic targets

C Sardu, G Paolisso, R Marfella - Current Pharmaceutical …, 2020 - ingentaconnect.com
Inflammation is a pathogenic response to multiple factors, that causes over-activation of
different molecules and pro-inflammatory cellular lines. Different behavioral factors and risk …